Cargando…

Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma

Interleukins (ILs) and interleukin receptors (ILRs) play important role in the antitumor immune response. However, the expression signature and clinical characteristics of the IL(R) family in lung adenocarcinoma (LUAD) remains unclear. The main purpose of this study was to explore the expression pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Tao, Pan, Shize, Yang, Shuo, Hao, Bo, Zhang, Lin, Li, Donghang, Geng, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419226/ https://www.ncbi.nlm.nih.gov/pubmed/34497605 http://dx.doi.org/10.3389/fimmu.2021.693062

Ejemplares similares

Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma
por: Pan, Shize, et al.
Publicado: (2022)

Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance
por: Pan, Shize, et al.
Publicado: (2022)

Identification of an inflammatory response signature associated with prognostic stratification and drug sensitivity in lung adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2022)

Comprehensive analysis reveals the potential value of inflammatory response genes in the prognosis, immunity, and drug sensitivity of lung adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2022)

Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma
por: Xiao, Junbo, et al.
Publicado: (2022)

Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis
por: Zhu, Mingchuang, et al.
Publicado: (2022)

Squamous cell carcinoma predicts worse prognosis than adenocarcinoma in stage IA lung cancer patients: A population-based propensity score matching analysis
por: Hao, Bo, et al.
Publicado: (2022)

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis
por: Zhu, Mingchuang, et al.
Publicado: (2022)

Prognostic and immunological significance of an M1 macrophage-related gene signature in osteosarcoma
por: Mao, Xiaoyu, et al.
Publicado: (2023)

Immunological Landscape and Clinical Management of Rectal Cancer
por: Pérez-Ruiz, Elísabeth, et al.
Publicado: (2016)

Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma
por: Wang, Yuli, et al.
Publicado: (2022)

Survival after wedge resection versus lobectomy for stage IA second primary NSCLC with previous lung cancer-directed surgery
por: Song, Congkuan, et al.
Publicado: (2022)

An Immunophenotyping of Ovarian Cancer With Clinical and Immunological Significance
por: Yang, Kai, et al.
Publicado: (2018)

Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma
por: Liu, Cong, et al.
Publicado: (2022)

Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

IL-17, IL-27, and IL-33: A Novel Axis Linked to Immunological Dysfunction During Sepsis
por: Morrow, Kristen N., et al.
Publicado: (2019)

The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier
por: Macleod, Tom, et al.
Publicado: (2021)

Immunological signature of patients with thymic epithelial tumors and Good syndrome
por: Malfitano, Anna Maria, et al.
Publicado: (2022)

The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes
por: Tang, Guoxing, et al.
Publicado: (2021)

Immune Cell Landscaping Reveals Distinct Immune Signatures of Inflammatory Bowel Disease
por: Bai, Xiaowu, et al.
Publicado: (2022)

Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma
por: Jang, Sung-Ill, et al.
Publicado: (2022)

Immunogenomic Landscape in Breast Cancer Reveals Immunotherapeutically Relevant Gene Signatures
por: Wang, Tao, et al.
Publicado: (2022)

Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy
por: Xu, Midie, et al.
Publicado: (2022)

Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis
por: Liu, Peng, et al.
Publicado: (2022)

Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial Cancer
por: Ramchander, Neal C., et al.
Publicado: (2020)

Immunological and Pathological Landscape of Dengue Serotypes 1-4 Infections in Immune-Competent Mice
por: Rathore, Abhay P. S., et al.
Publicado: (2021)

A five-collagen-based risk model in lung adenocarcinoma: prognostic significance and immune landscape
por: Dong, Lingjun, et al.
Publicado: (2023)

Landscape and Clinical Significance of Immune Checkpoint in Cutaneous Melanoma
por: Mao, Rui, et al.
Publicado: (2021)

Immunological Significance of HMGB1 Post-Translational Modification and Redox Biology
por: Kwak, Man Sup, et al.
Publicado: (2020)

Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures
por: Wang, Tao, et al.
Publicado: (2023)

Immunological significance of alternative splicing prognostic signatures for bladder cancer
por: Li, Xinyun, et al.
Publicado: (2022)

Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing
por: Yang, Jia, et al.
Publicado: (2023)

Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axis
por: Tang, Xi-Yang, et al.
Publicado: (2022)

Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma
por: Qiu, Chenjie, et al.
Publicado: (2021)

Clinical Significance and Immune Landscape of Recurrence-Associated Ferroptosis Signature in Early-Stage Lung Adenocarcinoma
por: Yi, Lilan, et al.
Publicado: (2022)

Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

Immune-related gene signature associates with immune landscape and predicts prognosis accurately in patients with Wilms tumour
por: Tian, Xiao-Mao, et al.
Publicado: (2022)

Mining of immunological and prognostic-related biomarker for cervical cancer based on immune cell signatures
por: Wang, Nana, et al.
Publicado: (2022)

Negative Regulation of the IL-1 System by IL-1R2 and IL-1R8: Relevance in Pathophysiology and Disease
por: Supino, Domenico, et al.
Publicado: (2022)

Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells
por: Bacchetta, Rosa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_291kf306fpjs9ktc0mqt3u2i7s